UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Breast cancer research : BCR, 2019-09, Vol.21 (1), p.108-108, Article 108

2019

Volltextzugriff (PDF)

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

European journal of cancer (1990), 2024-09, Vol.209, p.114270, Article 114270

2024

Volltextzugriff (PDF)

Concordance of genomic alterations between primary and recurrent breast cancer

Molecular cancer therapeutics, 2014-05, Vol.13 (5), p.1382-1389

2014

Volltextzugriff (PDF)

Associations between Taste Perception Profiles and Empirically Derived Dietary Patterns: An Exploratory Analysis among Older Adults with Metabolic Syndrome

Nutrients, 2021-12, Vol.14 (1), p.142

2021

Volltextzugriff (PDF)

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: A prospective study

Palliative medicine, 2014-04, Vol.28 (4), p.326-334

2014

Volltextzugriff (PDF)

AKT Inhibition in Solid Tumors With AKT1 Mutations

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2251-2259

2017

Volltextzugriff (PDF)

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

Journal of clinical oncology, 2018-11, Vol.36 (31), p.3134-3143

2018

Volltextzugriff (PDF)

MicroRNA profile in very young women with breast cancer

BMC cancer, 2014-07, Vol.14 (1), p.529-529, Article 529

2014

Volltextzugriff (PDF)

Non-Hodgkin's Lymphoma in Older People: Age Is Not Always an Adverse Prognostic Factor

Journal of the American Geriatrics Society (JAGS), 2002-11, Vol.50 (11), p.1911-1912

2002

Volltextzugriff (PDF)

Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based Chemotherapy

Clinical colorectal cancer, 2003-02, Vol.2 (4), p.231-234

2003

Volltextzugriff (PDF)

Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

Clinical & translational oncology, 2005-01, Vol.7 (1), p.23-28

2005

Volltextzugriff (PDF)

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer

Breast (Edinburgh), 2013-10, Vol.22 (5), p.974-979

2013

Volltextzugriff (PDF)

Pulmonary fibrosis induced by cyclophosphamide

The Annals of pharmacotherapy, 2001-07, Vol.35 (7-8), p.894-897

2001

Volltextzugriff (PDF)

Abstract CT331: “BEECH”, a phase I/II study of the AKT inhibitor AZD5363 combined with paclitaxel in patients with advanced or metastatic breast cancer: results from the dose-finding study, including quantitative assessment of circulating tumor DNA as a s

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT331-CT331

2015

Volltextzugriff (PDF)

High risk Ewing's sarcomas. Effectiveness and toxicity of a regimen designed for children and used in adults

Clinical & translational oncology, 2004-04, Vol.6 (3), p.165-169

2004

Volltextzugriff (PDF)

Abstract P3-13-01: Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-13-01

2015

Volltextzugriff (PDF)

Non-Hodgkin’s lymphoma in the elderly. Age is not always an adverse prognostic factor

Revista de oncología (Barcelona, Spain), 2002-11, Vol.4 (8), p.436-442

2002

Volltextzugriff (PDF)

Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2012-09, Vol.18 (17), p.4764-4774

2012

Volltextzugriff (PDF)

Melanoma of unknown primary: New perspectives for an old story

Critical reviews in oncology/hematology, 2021-02, Vol.158, p.103208-103208, Article 103208

2021

Volltextzugriff (PDF)

Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

Fundamental & clinical pharmacology, 2024-02, Vol.38 (1), p.183-191

2024

Volltextzugriff (PDF)

Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?

Gynecologic oncology, 2022-02, Vol.164 (2), p.406-414

2022

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(118)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

Concordance of genomic alterations between primary and recurrent breast cancer

Associations between Taste Perception Profiles and Empirically Derived Dietary Patterns: An Exploratory Analysis among Older Adults with Metabolic Syndrome

Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: A prospective study

AKT Inhibition in Solid Tumors With AKT1 Mutations

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

MicroRNA profile in very young women with breast cancer

Non-Hodgkin's Lymphoma in Older People: Age Is Not Always an Adverse Prognostic Factor

Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based Chemotherapy

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer

Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer

Pulmonary fibrosis induced by cyclophosphamide

Abstract CT331: “BEECH”, a phase I/II study of the AKT inhibitor AZD5363 combined with paclitaxel in patients with advanced or metastatic breast cancer: results from the dose-finding study, including quantitative assessment of circulating tumor DNA as a s

High risk Ewing's sarcomas. Effectiveness and toxicity of a regimen designed for children and used in adults

Abstract P3-13-01: Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial

Non-Hodgkin’s lymphoma in the elderly. Age is not always an adverse prognostic factor

Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors

Melanoma of unknown primary: New perspectives for an old story

Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?

Suchergebnisse filtern